Source · Select Committees · Women and Equalities Committee
Recommendation 33
33
Paragraph: 121
Evaluate merits of nationally rolling out the anti-mullarian hormone blood test for PCOS diagnosis.
Conclusion
The approval of the anti-mullarian hormone blood test as another tool to assist in the diagnosis of polycycstic ovary syndrome is a welcome development. NHS England should evaluate the merits of rolling it out nationally as a matter of priority.
Paragraph Reference:
121
Government Response
A response document is linked to this report, dated 5 March 2025. Response attribution to this conclusion has not been verified. Read the response document ↗